They include guidelines on frequency of PSA testing and digital rectal examination to detect and manage recurrence, management of common physical and psychosexual adverse treatment effects, interpretation of the DT, and referral information to relevant services (eg, sexual health and continence services).
To evaluate the patterns, the risk factors, and the management of recurrence following brachytherapy in patients with posterior uveal melanoma, given that an understanding of the recurrence patterns can improve early recognition and management of local treatment failure in such patients.
To analyze the TNM stage, management, and recurrence rates of patients with histologically confirmed squamous cell carcinoma (SCC) of the eyelid.
Despite continuous improvements in cancer management, locoregional recurrence or metastatic spread still occurs in a high proportion of patients after radiotherapy or combined treatments.
Prospectively evaluate the impact of fluorodeoxyglucose-fluorine-18 positron emission tomography (FDG-PET) in the management of recurrence of advanced head and neck squamous cell carcinoma during the first year after treatment.
Despite advances in treatment modalities and surgical techniques in recent years, the management of recurrence or distant metastasis remains a critical problem in treatment of HCC [ 1].
Even though this finding has led to the widespread use of TMZ for GBM management, tumour recurrence and mortality rate of these patients still remains very high, raising concerns regarding its actual effectiveness.
A more recent study by Kingsmore et al. [ 20] investigated the inter-relationship between adequacy of surgical management, locoregional recurrence and survival in 2,148 breast cancer patients treated with curative intent.
Not knowing why a baby died makes it difficult for health providers to counsel regarding future pregnancy management and recurrence risk and potentially magnifies the grief and bereavement outcomes for the family.
Other economic reviews have found the lifetime cost for treatment, follow-up, and management of recurrence and side effects to be $53 828 for PBT, $37 861 for IMRT, $25 484 for brachytherapy, $28 348 for radical prostatectomy, and $30 422 for active surveillance (Ollendorf et al, 2009).
